THERAHEART INC.

IRVINE, CA · Founded 2023 · CIK 0002092844 · Medtech · Private

Cardiac medical devices for heart disease treatment

theraheart.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$12M
1 Form D · Oct 2025
11 months since last filing
Contracts
—
No federal contracts on record
Patents
26
6 granted · 20 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$11,599,998
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
799ChemoMouthpiece, LLC—$16M
800Tulavi Therapeutics, Inc.—$13M
801MICROVASCULAR TISSUES, INC.—$12M
802THERAHEART INC.—$12M
803LADERX LLC—$67K
804AVEERA MEDICAL INC.—$8.8M
805NANOCAN THERAPEUTICS CORPORATION—$6.2M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Wei GanDirector · Executive Officer
  • Rani MahmoudiDirector
  • Sheng WangDirector

Patents

USPTO · 6 granted of 26

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.